Publications
30
Citations
551
Est. group size
~18
Recurring co-author estimate
Active years
18
Publishing since 2009
Morgan Robinson studies how amyloid-beta protein, cholesterol, and molecules like melatonin interact with and disrupt cell membranes, using techniques such as atomic force microscopy, molecular dynamics simulations, and cell viability assays, in the context of Alzheimer's disease. Much of the work focuses on how changes at the nanoscale in lipid membranes may contribute to the toxic effects seen in Alzheimer's disease, as well as on designing and testing potential inhibitor compounds that block amyloid-beta aggregation.
Publication output has been uneven over the past decade, with a burst of activity in 2017, a quiet period around 2018 and 2022, and a recent resurgence with a notably high output in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Dynamic instability in nanoscale lipid domains revealed by contact mode high speed AFM: effect of amyloid-β and cholesterol content
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Dynamic instability in nanoscale lipid domains revealed by contact mode high speed AFM: effect of amyloid-β and cholesterol content
Nanoscale Advances · 2025
- Atomic force microscopy and other scanning probe microscopy methods to study nanoscale domains in model lipid membranes
Advances in Physics X · 2023
- The Interplay Between Cholesterol and Amyloid-β on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling
Journal of Alzheimer s Disease · 2023
- Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies
International Journal of Molecular Sciences · 2021
- Chronic early-life social isolation affects NMDA and TrkB receptor expression in a sex-specific manner
Neuroscience Letters · 2021
- The effects of melatonin, serotonin, tryptophan and NAS on the biophysical properties of DPPC monolayers
Biochimica et Biophysica Acta (BBA) - Biomembranes · 2020
- Melatonin Alters Fluid Phase Coexistence in POPC/DPPC/Cholesterol Membranes
Biophysical Journal · 2020
- Effect of Melatonin on Lipid Membrane Structure and Membrane Interactions with Amyloid. An NMR and LSPR Study
Biophysical Journal · 2020
- Melatonin alters fluid phase co-existence in POPC/DPPC/cholesterol membranes
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- Changes in Lipid Membrane May Trigger Amyloid Toxicity in Alzheimer's Disease
Biophysical Journal · 2019
- Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
Journal of Alzheimer s Disease · 2017
- Recent Progress in Alzheimer’s Disease Research, Part 2: Genetics and Epidemiology
Journal of Alzheimer s Disease · 2017
- Pseudo-peptide amyloid-β blocking inhibitors: molecular dynamics and single molecule force spectroscopy study
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2017
- Analytical Approach for Modeling of Multi Well CO2 Injection
Energy Procedia · 2017
- bioRxiv (Cold Spring Harbor Laboratory)×8
- Journal of Alzheimer s Disease×3
- Biophysical Journal×3
- Journal of Neuroscience×1
- Biochimica et Biophysica Acta (BBA) - Biomembranes×1
- Jeff Kuret
Medicine · The Ohio State University
- Daniela Jimenez-Harrison
Medicine · The Ohio State University
- Debomoy K. Lahiri
Medicine · Indiana University
- Hossein Ashrafian
Medicine · The Ohio State University
- Kierra Eldridge
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile